Oritavancin
In Stock•Starting at $215 for 5 mg
| CAS No. | 171099-57-3 |
|---|---|
| MDL No. | N/A |
| MF | C86H97Cl3N10O26 |
| MW | 1793.10 |
| InChI Key | VHFGEBVPHAGQPI-LXKZPTCJSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 5 mg | To Be Confirmed | $215 | In Stock | |
| 25 mg | To Be Confirmed | $680 | In Stock | |
| 100 mg | To Be Confirmed | $2133 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Oritavancin is a semisynthetic glycopeptide used as its bisphosphate salt to treat acute bacterial skin and skin structure infections caused by susceptible Gram-positive microorganisms, including MRSA. It functions as an antibacterial drug and antimicrobial agent, and is a disaccharide derivative, glycopeptide, and semisynthetic derivative related to vancomycin aglycone.
| CAS No. | 171099-57-3 |
|---|---|
| Product Name | Oritavancin |
Associated Conditions
infection·bacterial disease·abscess·skin disease·cellulitis·
* The information provided here is compiled from public sources and is for reference only.
